Literature DB >> 1158946

The pathological basis for skeletal scintigraphy.

C S Galasko.   

Abstract

Skeletal scintigraphy, which has now been established as a useful and accurate method of detecting early skeletal metastases and assessing their response to treatment, has been investigated for its pathological basis. Histological examination of several hyndred necropsy specimens, from sixty-eight patients who died from malignant disease, showed a significant increase of osteoid and immature woven bone in the presence of metastatic cancer. Tumour-cell suspensions of the VX2 carcinoma were injected into the medullary cavity or on to the periosteal surface of the ilia or tibiae of New Zealand white rabbits. A combination of bone destruction and new bone formation, similar to the autopsy material, was seen. There were at least two mechanisms for the new bone production. Initially, intramembranous ossification was seen in the fibrous stroma surrounding the tumour. Once the cortex was involved and cortical bone destruction had occurred, large amounts of woven bone resembling fracture callus were laid down. The new bone had a markedly increased avidity for bone-seeking isotopes, indicating why skeletal scintigraphy was useful. A further twenty rabbits, in whose ilia the VX2 carcinoma was growing, were treated by local irradiation. When treatment was successful the tumour was destroyed, the production of new bone ceased, and the lesion lost its increased avidity for bone-seeking isotopes, indicating that skeletal scintigraphy could be used to assess the response of skeletal metastases to therapy.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1158946

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  21 in total

Review 1.  Review of running injuries of the foot and ankle: clinical presentation and SPECT-CT imaging patterns.

Authors:  Matthieu Pelletier-Galarneau; Patrick Martineau; Maxime Gaudreault; Xuan Pham
Journal:  Am J Nucl Med Mol Imaging       Date:  2015-06-15

Review 2.  The pathobiology of the osteoclast.

Authors:  T J Chambers
Journal:  J Clin Pathol       Date:  1985-03       Impact factor: 3.411

3.  Pitfalls in bone density monitoring in prostate cancer during anti-resorptive treatment.

Authors:  Y-M Cheung; S K Ramchand; M Grossmann
Journal:  Osteoporos Int       Date:  2018-04-17       Impact factor: 4.507

4.  Pathological fractures due to bone metastases.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1981-09-19

5.  Patterns and mechanisms of bone metastases.

Authors:  R L Carter
Journal:  J R Soc Med       Date:  1985       Impact factor: 5.344

Review 6.  The role of skeletal scanning in clinical oncology.

Authors:  J H McKillop; I R McDougall
Journal:  Br Med J       Date:  1980-08-09

7.  Bone histology at autopsy and matched bone scintigraphy findings in patients with hormone refractory prostate cancer: the effect of bisphosphonate therapy on bone scintigraphy results.

Authors:  M P Roudier; H Vesselle; L D True; C S Higano; S M Ott; S H King; R L Vessella
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

Review 8.  Fluorinated tracers for imaging cancer with positron emission tomography.

Authors:  Olivier Couturier; André Luxen; Jean-François Chatal; Jean-Philippe Vuillez; Pierre Rigo; Roland Hustinx
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-07-06       Impact factor: 9.236

9.  Bone marrow scintigraphy in the diagnosis of bone metastasis in prostate cancer.

Authors:  H Fuse; O Nagakawa; H Seto; T Katayama
Journal:  Int Urol Nephrol       Date:  1994       Impact factor: 2.370

10.  Myeloma affects both the growth and function of human osteoblast-like cells.

Authors:  C E Evans; C Ward; L Rathour; C B Galasko
Journal:  Clin Exp Metastasis       Date:  1992-01       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.